Back to mobile site

Akorn (AKRX) Ephedrine NDA Delayed - RBC Capital

July 18, 2016 1:02 PM EDT Send to a Friend
RBC Capital analyst Randall Stanicky said they reached out to Akorn (NASDAQ: AKRX) and understand that it has not yet ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login